iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3028% below fair value

$0.71−0.03 (-3.81%)

Close on Nov 11, 2026Market cap $1.79MP/E –Yield –

iSpecimen EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

iSpecimen's EPS for the twelve months ending Jun 30, 2026 was -$52.78. For fiscal 2025 it was -$91.20. The highest annual figure on record is -$91.20 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$91.20	–
FY2024	Dec 31, 2024	-$703.20	–
FY2023	Dec 31, 2023	-$982.00	–
FY2022	Dec 31, 2022	-$928.00	–
FY2021	Dec 31, 2021	-$1672.00	–
FY2020	Dec 31, 2020	-$3976.00	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$0.98	–
Q1 FY2026	Mar 31, 2026	-$6.66	–
Q4 FY2025	Dec 31, 2025	-$25.94	–
Q3 FY2025	Sep 30, 2025	-$19.20	–
Q2 FY2025	Jun 30, 2025	-$16.78	–
Q1 FY2025	Mar 31, 2025	-$28.55	–
Q4 FY2024	Dec 31, 2024	-$213.80	–
Q3 FY2024	Sep 30, 2024	-$84.00	–
Q2 FY2024	Jun 30, 2024	-$148.80	–
Q1 FY2024	Mar 31, 2024	-$254.40	–
Q4 FY2023	Dec 31, 2023	-$270.82	–
Q3 FY2023	Sep 30, 2023	-$186.40	–
Q2 FY2023	Jun 30, 2023	-$312.00	–
Q1 FY2023	Mar 31, 2023	-$216.00	–
Q4 FY2022	Dec 31, 2022	-$193.94	–
Q3 FY2022	Sep 30, 2022	-$280.00	–
Q2 FY2022	Jun 30, 2022	-$240.00	–
Q1 FY2022	Mar 31, 2022	-$216.00	–
Q3 FY2021	Sep 30, 2021	-$176.00	–
Q2 FY2021	Jun 30, 2021	-$696.00	–
Q1 FY2021	Mar 31, 2021	-$3384.00	–
Q4 FY2020	Dec 31, 2020	-$1362.00	–
Q3 FY2020	Sep 30, 2020	-$1064.00	–
Q2 FY2020	Jun 30, 2020	-$152.00	–